Delivery Order SPE2DB22D1041-SPE2DB25FTZC2
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,183.71, is a delivery order for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025 and was awarded on February 13, 2025. This contract award is not associated with a set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.40, is a Firm Fixed Price Delivery Order for the supply of the XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and was awarded on January 21, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,700.17, is a Delivery Order for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a firm fixed price pricing type and an ultimate completion date of December 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, with an ID of SPE2DB22D3009|SPE2DB24FBA74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,612.06, is a Delivery Order contract for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has an ultimate completion date of July 18, 2024 and is a Firm Fixed Price arrangement. It is not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,490.10 firm-fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,519.27, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,255.82, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of July 26, 2024 and is a Firm Fixed Price Delivery Order contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award, with the ID SPE2DB20D1100|SPE2DB25FY86J, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,040.68 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB20D1102|SPE2DB25FC5XG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,248.84 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of January 7, 2025 and was awarded on January 6, 2025. It is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,302.18 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of July 23, 2024. AmerisourceBergen is the prime contractor on this award and holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...